Cem Onur Kirac

Cem Onur Kirac

Auto-generated profile, based on publicly available information

Cem Onur Kirac

Department of Internal Medicine, Division of Endocrinology and Metabolism, Necip Fazil City Hospital, Kahramanmaras, Turkey

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2019 in Diagnosis
Verified
Journal Article
Closed access
PDF file
CKCem Onur Kirac
Cem Onur Kirac
SASedat Abusoglu
Sedat Abusoglu
EHEsra Paydas Hataysal
Esra Paydas Hataysal
AKAysegul Kebapcilar
Aysegul Kebapcilar
SISuleyman Hilmi Ipekci
Suleyman Hilmi Ipekci
LKLevent Kebapcilar
Levent Kebapcilar
Background: Subclinical hypothyroidism is a situation in which the thyroid-stimulating hormone (TSH) value exceeds the upper limit of normal, but the free triiodothyronine (T3) and thyroxine (T4) values are within the normal range. The etiology is similar to overt hypothyroidism. Case presentation: An 18-year-old female patient was referred to our endocrinology clinic due to elevated TSH levels detected during a routine examination. She was clinically euthyroid and had a normal thyroid ultrasound pattern. The TSH concentration was measured twice independently, giving values of 5.65 μIU/mL and 5.47 μIU/mL. The polyethylene glycol (PEG) method for TSH measurement was used to determine the concentration of macro-TSH (m-TSH), a macromolecule formed between TSH and immunoglobulin (Ig). Using the same blood samples for which the TSH levels were found to be high, the PEG method found TSH levels to be within a normal range, with values of 1.50 μIU/mL (5.65–1.50 μIU/mL measured; a decrease of 75%) and 1.26 μIU/mL (5.47–1.26 μIU/mL measured; a decrease of 77%), respectively. The TSH values determined by the PEG precipitation test were markedly low, with PEG-precipitable TSH ratios greater than 75%. Conclusions: The cause of 55% of subclinical hypothyroidism is chronic autoimmune thyroiditis. However, it is necessary to exclude other TSH-elevated conditions for diagnosis. One of these conditions is m-TSH, which should be kept in mind even though it is rarely seen. m-TSH should be considered especially in patients who have a TSH value above 10 μIU/mL without hypothyroidism symptoms or who require a higher levothyroxine replacement dose than expected to make them euthyroid.

1 January 2022 in European Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
CKCem Onur Kirac
Cem Onur Kirac
VSVehbi Sirikci
Vehbi Sirikci
HFHüseyin Avni Fındıklı
Hüseyin Avni Fındıklı
Introduction and aim. Thyroid hormones play an important role in glucose metabolism as in many metabolic events. The aim of our study is to evaluate the relationship between subclinical hypothyroidism (SCH) and insulin resistance, especially in obese women. Material and methods. Newly diagnosed SCH patients with body mass index (BMI) ≥30 who applied to our outpatient clinic between March 2021 and October 2021, and euthyroid obese women who applied for routine control were included in the study. In this study, we used homeostasis model assessment of insulin resistance (HOMA-IR) and triglyceride glucose (TyG) indexes, which are noninvasive, simple and useful methods for evaluating insulin sensitivity. Results. The study included 78 female patients between the ages of 19 and 64. A correlational analysis was performed between thyroid stimulating hormone (TSH) and HOMA-IR, TyG, and BMI. The results showed that TSH levels were positively correlated with HOMA-IR (R=0.297, p=0.008), TyG (R=0.316, p=0.005) and BMI (R=0.307, p=0.006). This relationship was stronger for TyG compared to the other variables. As another finding, BMI was positively correlated with HOMA-IR (R=0.359, p=0.001) and TyG (R=0.404, p<0.001). This relationship was stronger for TyG than HOMA-IR. Conclusion. These results show that patients with SCH are at risk of developing diseases that accompany insulin resistance, such as metabolic syndrome and cardiovascular disorders. The most important finding of our study is that the TyG index gives more significant results than HOMA-IR, especially in obese women.

20 May 2023 in Galician Medical Journal
Verified
Journal Article
Open access
PDF file
CKCem Onur Kirac
Cem Onur Kirac
VSVehbi Sirikci
Vehbi Sirikci
HFHüseyin Avni Fındıklı
Hüseyin Avni Fındıklı
Introduction.Graves’ disease is the most common cause of hyperthyroidism. The mortality rate increases by 20% in hyperthyroid patients; cardiac problems are the leading cause of death and arrhythmia is the most common cardiac complication. Our study aimed to evaluate the corrected QT interval (QTc), the Tpeak-Tend interval (Tp-e), and the Tp-e/QTc ratio to predict arrhythmia risk in patients with Graves’ disease. Methods. The study included 64 patients with Graves’ disease and 57 euthyroid controls. The 12-lead electrocardiograms of the individuals under study were evaluated. The QTc interval, the Tp-e interval, and the Tp-e/QTc ratio of all participants were determined and statistically evaluated with thyroid stimulating hormone (TSH), free triiodothyronine (fT3) and free thyroxine (fT4) values. Results. Tp-e (p < 0.001) and QTc (p < 0.05) were significantly prolonged in the group of patients with Graves’ disease as compared to the control group. Heart rate was higher in patients with Graves’ disease as well (p < 0.05). Correlation analysis in patients with hyperthyroidism demonstrated that Tp-e (r=0.372, p=0.002), QTc (r=0.291, p=0.020), and fT3 levels were significantly and positively correlated. Similarly, Tp-e (r=0.271, p=0.030), QTc (r=0.259, p=0.039), and fT4 levels were significantly and positively correlated. Conclusions. We observed a significant prolongation of the Tp-e and QTc intervals with the increase in fT3 and fT4 levels. On the other hand, our study demonstrated that the sensitivity and specificity of Tp-e in the prediction of hyperthyroidism were 70.3% and 70.1%, respectively (AUC=0.724 (CI: 0.629-0.818)), the optimal cut-off value=83.5 ms). The Tp-e interval, which has recently been used as one of the arrhythmogenicity indices, may be an indicator of arrhythmia risk in patients with Graves’ disease.

22 June 2018 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
CKCem Onur Kirac
Cem Onur Kirac
SISuleyman Hilmi Ipekci
Suleyman Hilmi Ipekci
LKLevent Kebapcilar
Levent Kebapcilar

6 September 2022 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
AÖAyşe Elverdi Özbek
Ayşe Elverdi Özbek
HKHüseyin Korkmaz
Hüseyin Korkmaz
MSMehmet Sözen
Mehmet Sözen
SISüleyman Hilmi İpEkçi
Süleyman Hilmi İpEkçi
SASedat Abuşoğlu
Sedat Abuşoğlu
LKLevent Kebapçılar
Levent Kebapçılar

29 September 2023 in Medicine
Verified
Journal Article
Open access
CKCem Onur Kirac
Cem Onur Kirac
VSVehbi Sirikci
Vehbi Sirikci
HFHüseyin Avni Fındıklı
Hüseyin Avni Fındıklı
Lipohypertrophy (LH) is a major localized complication of insulin therapy. We aimed to investigate the association between insulin-induced LH and carotid intima-media thickness (CIMT) in patients with type 2 diabetes mellitus (DM). A total of 75 patients with DM treated with insulin were included in this study. The insulin injection sites of the patients were evaluated by inspection and palpation and then radiologically with ultrasound. The CIMT of the patients was evaluated using ultrasonography. According to the guideline recommendation, the CIMT cutoff value was taken as 0.9 mm, and the patients were categorized into 2 groups according to the CIMT value and evaluated statistically. The presence of LH (CI: 1.379–30.000; OR = 6.432; P < .05), age (CI: 1.036–1.149; OR = 1091; P < .05), BMI (CI: 1.003–1.262; OR = 1.125; P < .05) and duration of DM (CI: 1.001–1.300; OR = 1.141; P < .05) were independent risk factors for high-CIMT in patients with DM. The most interesting result of this study was that the presence of LH was an independent risk factor for increased CIMT. According to this result, we think that LH may increase the risk of cardiovascular disease as well as being a complication that disrupts the blood glucose regulation of patients with DM and increases the cost of treatment.